company background image
PGNY logo

Progyny NasdaqGS:PGNY Stock Report

Last Price

US$13.77

Market Cap

US$1.2b

7D

-17.1%

1Y

-57.2%

Updated

17 Nov, 2024

Data

Company Financials +

Progyny, Inc.

NasdaqGS:PGNY Stock Report

Market Cap: US$1.2b

PGNY Stock Overview

A benefits management company, specializes in fertility and family building benefits solutions in the United States. More details

PGNY fundamental analysis
Snowflake Score
Valuation6/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 84% below our estimate of its fair value

Earnings are forecast to grow 19.85% per year

Earnings have grown 26.9% per year over the past 5 years

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 39.8%

Risk Analysis

Volatile share price over the past 3 months compared to the US market


Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Growing Partnerships And Innovative Services Drive Revenue Surge Amid Market Challenges

Key Takeaways Strong demand for new services and strategic partnerships with health plans are set to enhance market reach and drive revenue growth. High client acquisition, stable utilization rates, and a strong renewal rate indicate robust growth potential and customer satisfaction.
View narrative
US$24.38
FV
43.5% undervalued intrinsic discount
9.45%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
3 days ago author updated this narrative

Progyny, Inc. Competitors

HealthEquity

NasdaqGS:HQY

US$8.6b

Molina Healthcare

NYSE:MOH

US$16.8b

Centene

NYSE:CNC

US$29.0b

Humana

NYSE:HUM

US$33.2b

Price History & Performance

Summary of all time highs, changes and price drops for Progyny
Historical stock prices
Current Share PriceUS$13.77
52 Week HighUS$42.08
52 Week LowUS$13.39
Beta1.44
11 Month Change-18.28%
3 Month Change-34.99%
1 Year Change-57.24%
33 Year Change-76.80%
5 Year Change-46.38%
Change since IPO-13.61%

Recent News & Updates

Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Oct 21
Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny: Poor Year Raises Concerns For Future (Downgrade)

Oct 15

Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Sep 29
Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Recent updates

Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Oct 21
Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny: Poor Year Raises Concerns For Future (Downgrade)

Oct 15

Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Sep 29
Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Progyny: Downgrading As Uncertainties Increase

Aug 15

Progyny, Inc. (NASDAQ:PGNY) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing

Aug 11
Progyny, Inc. (NASDAQ:PGNY) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing

At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Jul 20
At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Progyny: Recent Stock Decline Provides Buying Opportunity

Jul 12

Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall

Jun 23
Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall

Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore

Jun 10

Progyny: No Change To Long-Term Outlook

Jun 04

Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Apr 29
Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Apr 03
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Progyny: Long-Term Outlook Remains Positive, Reiterate Buy

Mar 15

Progyny: Long-Term Thesis Still Intact

Mar 09

Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Mar 01
Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Jan 07
Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Dec 11
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Nov 08
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Aug 24
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Aug 06
There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

May 06
Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Jan 25
When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Dec 12
Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Is It Time To Consider Buying Progyny, Inc. (NASDAQ:PGNY)?

Oct 18
Is It Time To Consider Buying Progyny, Inc. (NASDAQ:PGNY)?

Shareholder Returns

PGNYUS HealthcareUS Market
7D-17.1%-3.7%-2.1%
1Y-57.2%2.8%30.2%

Return vs Industry: PGNY underperformed the US Healthcare industry which returned 2.8% over the past year.

Return vs Market: PGNY underperformed the US Market which returned 30.2% over the past year.

Price Volatility

Is PGNY's price volatile compared to industry and market?
PGNY volatility
PGNY Average Weekly Movement11.6%
Healthcare Industry Average Movement7.0%
Market Average Movement6.2%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.1%

Stable Share Price: PGNY's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: PGNY's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2008565Pete Anevskiwww.progyny.com

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.

Progyny, Inc. Fundamentals Summary

How do Progyny's earnings and revenue compare to its market cap?
PGNY fundamental statistics
Market capUS$1.17b
Earnings (TTM)US$57.27m
Revenue (TTM)US$1.14b

20.5x

P/E Ratio

1.0x

P/S Ratio

Is PGNY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PGNY income statement (TTM)
RevenueUS$1.14b
Cost of RevenueUS$891.91m
Gross ProfitUS$246.83m
Other ExpensesUS$189.55m
EarningsUS$57.27m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.67
Gross Margin21.68%
Net Profit Margin5.03%
Debt/Equity Ratio0%

How did PGNY perform over the long term?

See historical performance and comparison